End-of-day quote
Shanghai S.E.
06:00:00 2024-04-29 pm EDT
|
5-day change
|
1st Jan Change
|
9.71
CNY
|
+2.97%
|
|
+12.91%
|
-22.07%
|
Fiscal Period: December |
2019
|
2020
|
2021
|
2022
|
2023
|
2024
|
2025
|
---|
Capitalization
1 |
3,190
|
11,588
|
17,857
|
13,082
|
7,041
|
5,487
|
-
|
Enterprise Value (EV)
1 |
3,190
|
11,588
|
17,857
|
13,082
|
7,041
|
5,487
|
5,487
|
P/E ratio
|
25.1
x
|
50.2
x
|
50.7
x
|
16.3
x
|
-5.72
x
|
15.7
x
|
7.53
x
|
Yield
|
-
|
-
|
-
|
-
|
-
|
1.65%
|
4.02%
|
Capitalization / Revenue
|
-
|
6.05
x
|
4.41
x
|
0.93
x
|
0.81
x
|
0.4
x
|
0.36
x
|
EV / Revenue
|
-
|
6.05
x
|
4.41
x
|
0.93
x
|
0.81
x
|
0.4
x
|
0.36
x
|
EV / EBITDA
|
-
|
35
x
|
29.4
x
|
9.13
x
|
-5.24
x
|
4.22
x
|
2.85
x
|
EV / FCF
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
FCF Yield
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
Price to Book
|
-
|
6.02
x
|
8.04
x
|
2.77
x
|
2.04
x
|
1.44
x
|
1.23
x
|
Nbr of stocks (in thousands)
|
423,658
|
482,116
|
482,091
|
565,079
|
565,079
|
565,079
|
-
|
Reference price
2 |
7.529
|
24.04
|
37.04
|
23.15
|
12.46
|
9.710
|
9.710
|
Announcement Date
|
4/29/20
|
3/26/21
|
4/8/22
|
4/26/23
|
4/28/24
|
-
|
-
|
Fiscal Period: December |
2019
|
2020
|
2021
|
2022
|
2023
|
2024
|
2025
|
---|
Net sales
1 |
-
|
1,915
|
4,054
|
14,072
|
8,729
|
13,561
|
15,368
|
EBITDA
1 |
-
|
331.3
|
606.9
|
1,432
|
-1,345
|
1,299
|
1,927
|
EBIT
1 |
-
|
272.1
|
506.4
|
1,158
|
-1,834
|
445
|
736
|
Operating Margin
|
-
|
14.21%
|
12.49%
|
8.23%
|
-21%
|
3.28%
|
4.79%
|
Earnings before Tax (EBT)
1 |
-
|
273.3
|
506.5
|
1,161
|
-1,831
|
445
|
736
|
Net income
1 |
127.4
|
202.8
|
350.8
|
752.9
|
-1,233
|
351
|
730
|
Net margin
|
-
|
10.59%
|
8.66%
|
5.35%
|
-14.13%
|
2.59%
|
4.75%
|
EPS
2 |
0.3000
|
0.4786
|
0.7300
|
1.420
|
-2.180
|
0.6200
|
1.290
|
Free Cash Flow
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
FCF margin
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
FCF Conversion (EBITDA)
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
FCF Conversion (Net income)
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
Dividend per Share
2 |
-
|
-
|
-
|
-
|
-
|
0.1600
|
0.3900
|
Announcement Date
|
4/29/20
|
3/26/21
|
4/8/22
|
4/26/23
|
4/28/24
|
-
|
-
|
Fiscal Period: December |
2019
|
2020
|
2021
|
2022
|
2023
|
2024
|
2025
|
---|
Net Debt
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
Net Cash position
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
Leverage (Debt/EBITDA)
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
Free Cash Flow
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
ROE (net income / shareholders' equity)
|
-
|
14.2%
|
17.1%
|
21.1%
|
-30.2%
|
9.7%
|
17.7%
|
ROA (Net income/ Total Assets)
|
-
|
7.91%
|
7.74%
|
7.24%
|
-
|
1.9%
|
3.5%
|
Assets
1 |
-
|
2,563
|
4,531
|
10,398
|
-
|
18,474
|
20,857
|
Book Value Per Share
2 |
-
|
3.990
|
4.610
|
8.360
|
6.110
|
6.730
|
7.870
|
Cash Flow per Share
2 |
-
|
0.6300
|
-0.8500
|
-5.750
|
1.570
|
0.7800
|
2.470
|
Capex
1 |
-
|
248
|
509
|
1,116
|
2,144
|
2,560
|
1,860
|
Capex / Sales
|
-
|
12.94%
|
12.56%
|
7.93%
|
24.56%
|
18.88%
|
12.1%
|
Announcement Date
|
4/29/20
|
3/26/21
|
4/8/22
|
4/26/23
|
4/28/24
|
-
|
-
|
Last Close Price
9.71
CNY Average target price
12.1
CNY Spread / Average Target +24.61% Consensus |
1st Jan change
|
Capi.
|
---|
| -22.07% | 758M | | +14.70% | 64.83B | | -1.61% | 46.29B | | +14.58% | 40.05B | | +20.84% | 26.72B | | +1.16% | 17.45B | | -21.87% | 15.82B | | +1.11% | 15.02B | | -11.34% | 14.73B | | -20.82% | 13.34B |
Other Specialty Chemicals
|